Rekah Pharmaceutical Industry Ltd. (REKA) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months

Poor long term growth as Net Sales has grown by an annual rate of 7.12% and Operating profit at -180.04% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

With ROE of -7.76%, it has a Expensive valuation with a 0.87 Price to Book Value

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

ILS 135 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.62

Return on Equity

-7.76%

Price to Book

0.87

Revenue and Profits:

Net Sales:

76 Million

(Quarterly Results - Mar 2025)

Net Profit:

-2 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.95%

6 Months

-14.58%

1 Year

-15.44%

2 Years

-30.2%

3 Years

-28.58%

4 Years

-47.98%

5 Years

-53.01%

Rekah Pharmaceutical Industry Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

7.12%

EBIT Growth (5y)

-180.04%

EBIT to Interest (avg)

1.22

Debt to EBITDA (avg)

2.80

Net Debt to Equity (avg)

0.55

Sales to Capital Employed (avg)

1.15

Tax Ratio

55.77%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

4.09%

ROE (avg)

2.78%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.87

EV to EBIT

-42.74

EV to EBITDA

8.75

EV to Capital Employed

0.92

EV to Sales

0.74

PEG Ratio

Dividend Yield

ROCE (Latest)

-2.15%

ROE (Latest)

-7.76%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

Bearish

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -0.13% vs -12.61% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -4.35% vs 51.06% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "76.10",
          "val2": "76.20",
          "chgp": "-0.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.20",
          "val2": "8.10",
          "chgp": "1.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "0.40",
          "chgp": "375.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "-1.40",
          "chgp": "85.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.40",
          "val2": "-2.30",
          "chgp": "-4.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.00%",
          "val2": "2.40%",
          "chgp": "-0.04%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 10.02% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 189.86% vs -245.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "321.70",
          "val2": "321.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.80",
          "val2": "35.30",
          "chgp": "-24.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.60",
          "val2": "10.00",
          "chgp": "-24.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.40",
          "val2": "-0.60",
          "chgp": "-133.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.20",
          "val2": "-6.90",
          "chgp": "189.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-18.10%",
          "val2": "16.70%",
          "chgp": "-3.48%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ

Mar'25

Dec'24

Change(%)

Net Sales

76.10

76.20

-0.13%

Operating Profit (PBDIT) excl Other Income

8.20

8.10

1.23%

Interest

1.90

0.40

375.00%

Exceptional Items

-0.20

-1.40

85.71%

Consolidate Net Profit

-2.40

-2.30

-4.35%

Operating Profit Margin (Excl OI)

2.00%

2.40%

-0.04%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2025 is -0.13% vs -12.61% in Dec 2024

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is -4.35% vs 51.06% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

321.70

Operating Profit (PBDIT) excl Other Income

26.80

35.30

-24.08%

Interest

7.60

10.00

-24.00%

Exceptional Items

-1.40

-0.60

-133.33%

Consolidate Net Profit

6.20

-6.90

189.86%

Operating Profit Margin (Excl OI)

-18.10%

16.70%

-3.48%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 10.02% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 189.86% vs -245.00% in Dec 2023

All Annual Results

Company CV

About

Company Coordinates

Company Details

Tel:

Registrar Details